Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Senate Chooses Baucus Approach To Comp. Effectiveness, With Tweaks

This article was originally published in The Gray Sheet

Executive Summary

The Senate health reform 1bill up for floor debate this week essentially retains the industry-supported Baucus/Conrad approach to a national comparative effectiveness research infrastructure, but includes some subtle changes of note

You may also be interested in...



Ups And Downs For Lab Tests In Senate Health Reform Bill

Senate health care reform 1legislation up for floor debate this week contains both positives and negatives for makers of in vitro diagnostics and for testing labs, but would reduce expected Medicare payment cuts in the sector compared to the package approved by the Senate Finance Committee last month

Health Reform Taxes: Senate Reduces Device Fee, Adds Cosmetic Surgery Tax

Consensus on Capitol Hill is centering on a total tax to the device industry of $20 billion over 10 years to help cover health care reform spending, but the structure of the tax and how it will be allocated remain up in the air

Consensus Emerging On Need To Mesh CER And Personalized Medicine

A distinct consensus is emerging in Washington that comparative effectiveness research needs to be done in a way that does not threaten the progress of personalized medicine

Related Content

Topics

UsernamePublicRestriction

Register

LL1134940

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel